HG

Harsh Garg

Active Director Director DIN 09591174
DIN 09591174 First appointment Apr 2022 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Harsh Garg

Data last updated:

Harsh Garg is a Director at Medoc Pharmaceuticals Private Limited (since 2022). The company operates in Electrnoics. Medoc Pharmaceuticals Private Limited reported revenue of ₹4.6 Lakh (FY 2024).

DIN 09591174
Primary Designation Director
Industry Electrnoics
First Appointment 29 Apr 2022
Oldest Company Age 4 yrs
Largest company Medoc Pharmaceuticals Private Limited · ₹4.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Apr 20222022₹4.6 Lakh (FY 2024)Active

Board colleagues of Harsh Garg

NameDINCompanyDesignation
Vijay Kumar Gupta10413338Medoc Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medoc Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Harsh Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harsh Garg

Harsh Garg currently holds 1 directorship: Medoc Pharmaceuticals Private Limited (Director, since 29 Apr 2022, revenue ₹4.6 Lakh (FY 2024)).

Harsh Garg was first appointed on 29 Apr 2022 as Director at Medoc Pharmaceuticals Private Limited.

The current boards of Harsh Garg's companies include Vijay Kumar Gupta (Medoc Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available